RxDoctor Payments DataLook up a doctor →

Jordan Perez

Family · Saint Louis, MONPI 1851910947

Payments from drug & device makers

$43,244in general payments, 2019–2025

Across 616 payments — averaging $70.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$37K
  • Supernus Pharmaceuticals, Inc.$698
  • Pfizer$501
  • Biohaven Pharmaceutical Holding Company Ltd.$392
  • UCB, Inc.$354
  • Biohaven Pharmaceuticals, Inc.$317
  • plus $4K from 37 others

What the payments were for

  • Speaking & faculty fees$28,61366%
  • Travel & lodging$4,30610%
  • Food & beverage$10,32624%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,244 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$52,750
Medicare patients
71
Services billed
6,914

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate24$51,954
QuliptaAtogepant12$20,762
UbrelvyUbrogepant14$15,323
Aimovig AutoinjectorErenumab-Aooe13$9,524
Gabapentin78$2,236
Propranolol Hcl ErPropranolol Hcl17$731
Nortriptyline Hcl58$689
Carbidopa-LevodopaCarbidopa/Levodopa20$641
Levetiracetam26$585
Lamotrigine24$495
Propranolol Hcl25$428
Baclofen22$332
RizatriptanRizatriptan Benzoate32$277
Zonisamide16$268
Topiramate20$257

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$501$51,95424 claims
AbbVieQulipta, Ubrelvy$37,010$36,08526 claims
Upsher-smith Laboratories LLCTopiramate$14$25720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.

Other family in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →